Lis Y - Search Results

1

Encepp-HTA Working Group Survey on Capacity To Conduct Research in Support Of Health Technology Assessment.

Toussi M, Lis Y, Qizilbash N, Blake KV, Ehrenstein V, Kurz X, Moore N, Sinclair M. Toussi M, et al. Among authors: lis y. Value Health. 2014 Nov;17(7):A440. doi: 10.1016/j.jval.2014.08.1151. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201177 Free article. No abstract available.

2

Patient Reported Outcomes and Their Relevance in Reimbursement Decisions.

Stoddart S, Lis Y, Malmenas M. Stoddart S, et al. Among authors: lis y. Value Health. 2014 Nov;17(7):A421. doi: 10.1016/j.jval.2014.08.1035. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201068 Free article. No abstract available.

3

Comparisons of Food and Drug Administration and European Medicines Agency risk management implementation for recent pharmaceutical approvals: report of the International Society for Pharmacoeconomics and outcomes research risk benefit management working group.

Lis Y, Roberts MH, Kamble S, J Guo J, Raisch DW. Lis Y, et al. Value Health. 2012 Dec;15(8):1108-18. doi: 10.1016/j.jval.2012.06.019. Epub 2012 Nov 3. Value Health. 2012. PMID: 23244814 Free article.

4

A review of quantitative risk-benefit methodologies for assessing drug safety and efficacy-report of the ISPOR risk-benefit management working group.

Guo JJ, Pandey S, Doyle J, Bian B, Lis Y, Raisch DW. Guo JJ, et al. Among authors: lis y. Value Health. 2010 Aug;13(5):657-66. doi: 10.1111/j.1524-4733.2010.00725.x. Epub 2010 Apr 15. Value Health. 2010. PMID: 20412543 Free article. Review.

5

The impact of dosing frequency on compliance and persistence with bisphosphonates among postmenopausal women in the UK: evidence from three databases.

Brankin E, Walker M, Lynch N, Aspray T, Lis Y, Cowell W. Brankin E, et al. Among authors: lis y. Curr Med Res Opin. 2006 Jul;22(7):1249-56. doi: 10.1185/030079906X112688. Curr Med Res Opin. 2006. PMID: 16834823

6

The incidence of metamizole sodium-induced agranulocytosis in Poland.

Maj S, Lis Y. Maj S, et al. Among authors: lis y. J Int Med Res. 2002 Sep-Oct;30(5):488-95. doi: 10.1177/147323000203000504. J Int Med Res. 2002. PMID: 12449518 Free article.

7

Expression and functional analysis of the anaplastic lymphoma kinase (ALK) gene in tumor cell lines.

Dirks WG, Fähnrich S, Lis Y, Becker E, MacLeod RA, Drexler HG. Dirks WG, et al. Among authors: lis y. Int J Cancer. 2002 Jul 1;100(1):49-56. doi: 10.1002/ijc.10435. Int J Cancer. 2002. PMID: 12115586 Free article.

8

The VAMP Research multi-purpose database in the U.K.

Lis Y, Mann RD. Lis Y, et al. J Clin Epidemiol. 1995 Mar;48(3):431-43. doi: 10.1016/0895-4356(94)00137-f. J Clin Epidemiol. 1995. PMID: 7897464 No abstract available.

9

A study of the association between hormone replacement therapy, smoking and the occurrence of myocardial infarction in women.

Mann RD, Lis Y, Chukwujindu J, Chanter DO. Mann RD, et al. Among authors: lis y. J Clin Epidemiol. 1994 Mar;47(3):307-12. doi: 10.1016/0895-4356(94)90014-0. J Clin Epidemiol. 1994. PMID: 8138842

10

Novel medicines marketed in the UK (1960-87).

Lis Y, Walker SR. Lis Y, et al. Br J Clin Pharmacol. 1989 Sep;28(3):333-43. doi: 10.1111/j.1365-2125.1989.tb05435.x. Br J Clin Pharmacol. 1989. PMID: 2789928 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page